Impaired Hearing in Mitochondrial Disorders

Impaired Hearing in Mitochondrial Disorders

Bibliographic Details
Main Authors:	Josef Finsterer, Sinda Zarrouk-Mahjoub
Format:	Article
Language:	English
Published:	Wolters Kluwer 2015-01-01
Series:	Chinese Medical Journal
Online Access:	http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=13;spage=1839;epage=1839;aulast=Finsterer

Similar Items

MicroRNAs are inappropriate for characterising hearing impairment in mitochondrial disorders
by: Josef Finsterer, et al.
Published: (2018-05-01)

Pancreatitis in mitochondrial disorders
by: Josef Finsterer, et al.
Published: (2017-03-01)

Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed
by: Josef Finsterer, et al.
Published: (2017-12-01)

Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset
by: Josef Finsterer, et al.
Published: (2016-02-01)

Treating mitochondrial disorders requires full exploitation of available therapeutic options
by: Josef Finsterer, et al.
Published: (2017-12-01)

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene
by: Josef Finsterer, et al.
Published: (2017-12-01)

Clozapine for mitochondrial psychosis
by: Josef Finsterer, et al.
Published: (2017-03-01)

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
by: Josef Finsterer, et al.
Published: (2018-03-01)

Mitochondrial myopathy, dysmorphism, exercise-induced vomiting and tachycardia the mutation m.4831G > A
by: Josef Finsterer, et al.
Published: (2017-06-01)

Posterior Spinal Instrumented Fusion for Idiopathic Scoliosis in Patients with Multisystemic Neurodegenerative Disorder: A Report of Two Cases
by: Josef Finsterer, et al.
Published: (2016-12-01)

Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders
by: Finsterer J, et al.
Published: (2017-10-01)

Stroke in MELAS is a Vasogenic Edema and not Ischemic
by: Josef Finsterer, et al.
Published: (2020-05-01)

Letter to the Editor: Do not only ablate but also look for myocardial fibrosis and myopathy in noncompaction
by: Sinda Zarrouk-mahjoub, et al.
Published: (2015-12-01)

Editöre Mektup - Noncompaction on scleroderma
by: Sinda Zarrouk Mahjoub, et al.
Published: (2016-04-01)

Left ventricular hypertrabeculation/noncompaction in hyperoxaluria
by: Josef Finsterer, et al.
Published: (2015-09-01)

Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG
by: Josef Finsterer, et al.
Published: (2017-03-01)

ND2 mutation with minimal coenzyme-Q responsive manifestations
by: Josef Finsterer, et al.
Published: (2017-03-01)

Onset of MELAS due to the m.3243A>G mutation is early if the large phenotypic variability is considered
by: Josef Finsterer, et al.
Published: (2017-03-01)

Specification of the myopathy type may influence the management of noncompaction
by: Josef Finsterer, et al.
Published: (2016-01-01)

Fentanyl can be mitochondrion -toxic depending on dosage and cell type
by: Josef Finsterer, et al.
Published: (2019-01-01)

Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG
by: Josef Finsterer, et al.
Published: (2017-06-01)

Arrhythmias in MELAS syndrome
by: Josef Finsterer, et al.
Published: (2016-06-01)

Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation
by: Josef Finsterer, et al.
Published: (2016-01-01)

Assessment of the phenotype genotype variability and correlation in m.3243A>G mutation carriers requires prospective studies
by: Josef Finsterer, et al.
Published: (2016-09-01)

MELAS syndrome due to the m.3291T>C mutation
by: Josef Finsterer, et al.
Published: (2016-06-01)

Transient symmetric T2-hyperintensities of basal ganglia and brainstem not only point to Leigh syndrome
by: Josef Finsterer, et al.
Published: (2016-01-01)

KEARNS-SAYRE SYNDROME MIGHT BE MIXED UP WITH CPEO PLUS
by: Josef Finsterer, et al.
Published: (2019-01-01)

Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation
by: Josef Finsterer, et al.
Published: (2016-01-01)

Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation
by: Josef Finsterer, et al.
Published: (2017-03-01)

MELAS reflects a clinical concept with heterogeneous genetic background
by: Josef Finsterer, et al.

Diagnosis of Kearns-Sayre Syndrome Requires Comprehensive Work-up
by: Josef Finsterer, et al.
Published: (2016-01-01)

Letter to the Editor: Maternally Inherited Diabetes and Deafness is Not Only Biorgan but Multiorgan
by: Josef Finsterer, et al.
Published: (2017-09-01)

Carriers of POLG1 variants require investigations for multisystem disease and for mtDNA variations
by: Josef Finsterer, et al.
Published: (2022-07-01)

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
by: Sinda Zarrouk, et al.
Published: (2021-09-01)

Impaired Hearing in MELAS
by: Josef Finsterer
Published: (2022-05-01)

Why does Leigh syndrome respond to immunotherapy?
by: Josef Finsterer, MD, PhD, et al.
Published: (2017-06-01)

Are NO Precursors Truly Effective in MELAS?
by: Josef Finsterer MD, PhD, et al.
Published: (2018-08-01)

Before blaming SARS-CoV-2 infection or vaccination for acute peripheral artery occlusion, rule out differential causes
by: Josef Finsterer, et al.
Published: (2023-09-01)

The Role of Primary Mitochondrial Disorders in Hearing Impairment: An Overview
by: Virginia Fancello, et al.
Published: (2023-03-01)

Doping May Be Responsible for De Novo Mitochondrial Disorder
by: Josef Finsterer
Published: (2019-06-01)